R. Kwakman

542 total citations
11 papers, 395 citations indexed

About

R. Kwakman is a scholar working on Surgery, Reproductive Medicine and Critical Care and Intensive Care Medicine. According to data from OpenAlex, R. Kwakman has authored 11 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Reproductive Medicine and 2 papers in Critical Care and Intensive Care Medicine. Recurrent topics in R. Kwakman's work include Intraperitoneal and Appendiceal Malignancies (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and Intensive Care Unit Cognitive Disorders (2 papers). R. Kwakman is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and Intensive Care Unit Cognitive Disorders (2 papers). R. Kwakman collaborates with scholars based in Netherlands, Australia and South Africa. R. Kwakman's co-authors include Gerrit A. Meijer, Erienne M.V. de Cuba, E. A. te Velde, H. Jaap Bonjer, Dirk L. Knol, Geert Kazemier, Elisabeth A. te Velde, Nina R. Sluiter, René H.J. Otten and David McWilliams and has published in prestigious journals such as Annals of Surgery, British Journal of Cancer and Annals of Oncology.

In The Last Decade

R. Kwakman

10 papers receiving 391 citations

Peers

R. Kwakman
Sanjeev Dayal United Kingdom
Mackenzie C. Morris United States
Jessica A. Naiditch United States
Haney Youssef United Kingdom
K. Long United States
T Becker United States
H.J. Braam Netherlands
Sanjeev Dayal United Kingdom
R. Kwakman
Citations per year, relative to R. Kwakman R. Kwakman (= 1×) peers Sanjeev Dayal

Countries citing papers authored by R. Kwakman

Since Specialization
Citations

This map shows the geographic impact of R. Kwakman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kwakman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kwakman more than expected).

Fields of papers citing papers by R. Kwakman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Kwakman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kwakman. The network helps show where R. Kwakman may publish in the future.

Co-authorship network of co-authors of R. Kwakman

This figure shows the co-authorship network connecting the top 25 collaborators of R. Kwakman. A scholar is included among the top collaborators of R. Kwakman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Kwakman. R. Kwakman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Oijen, Marcel van, R. Kwakman, & Cornelis J.A. Punt. (2020). SO-19 S-1 is a cost-effective alternative to capecitabine in metastatic colorectal cancer. Annals of Oncology. 31. S224–S224.
2.
Kwakman, R., Arnold Baars, Henk Boot, et al.. (2017). Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in Western cancer patients. European Journal of Cancer. 72. S69–S69. 1 indexed citations
4.
Cuba, Erienne M.V. de, Ignace H. J. T. de Hingh, Nina R. Sluiter, et al.. (2016). Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer. Annals of Surgical Oncology. 23(5). 1601–1608. 13 indexed citations
5.
Kwakman, R., Michelle E. Kho, Bronwen Connolly, et al.. (2016). Surviving critical illness: what is next? An expert consensus statement on physical rehabilitation after hospital discharge. Critical Care. 20(1). 354–354. 91 indexed citations
6.
Sluiter, Nina R., Erienne M.V. de Cuba, R. Kwakman, et al.. (2016). Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Clinical & Experimental Metastasis. 33(4). 297–307. 18 indexed citations
7.
Sluiter, Nina R., et al.. (2016). Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options. Clinical & Experimental Metastasis. 33(5). 401–416. 42 indexed citations
8.
Kwakman, R., Michelle E. Kho, Bronwen Connolly, et al.. (2016). Surviving critical illness: what is next?. 1 indexed citations
9.
Kwakman, R., Erienne M.V. de Cuba, Peter de Winter, et al.. (2015). Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival. British Journal of Cancer. 112(5). 851–856. 14 indexed citations
10.
Cuba, Erienne M.V. de, R. Kwakman, Dirk L. Knol, et al.. (2012). Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases. Cancer Treatment Reviews. 39(4). 321–327. 93 indexed citations
11.
Cuba, Erienne M.V. de, R. Kwakman, Marjolein van Egmond, et al.. (2012). Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 461(3). 231–243. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026